Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
S-1 vs Capecitabine in Metastatic Colorectal Cancer (SALTO)
NCT01918852Phase 3Completed
- Sponsor
- Dutch Colorectal Cancer Group
- Start
- Dec 2013
- Primary completion
- Dec 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of tegafur in metastatic colorectal cancer (mCRC), sponsored by Dutch Colorectal Cancer Group. Started Dec 2013; status: completed.
02
Drugs
tegafur
03
Conditions
metastatic colorectal cancer (mCRC)
Beyond the preview
Go deeper on NCT01918852.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01918852.